Filing Flows › Fresenius Medical Care AG (FMS) › Capital expenditures
Fresenius Medical Care AG (FMS) capital expenditures by quarter
Fresenius Medical Care AG's capital expenditures were $238M in Q3 2026 (third quarter 2026), -44% from Q4 2025. Over the last 3 quarters it ranged from $192M (Q3 2025) to $423M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $238M | -44% | +24% |
| Q4 2025 | $423M | +120% | — |
| Q3 2025 | $192M | — | — |
Q3 2026 at a glance
Fresenius Medical Care AG, Q3 2026: revenue $4.9B (+1% year over year), operating margin 7.8%, net earnings $160M, operating cash flow $798M. The chart follows the revenue to costs, profit and cash.
Questions
What is Fresenius Medical Care AG's capital expenditures?
Fresenius Medical Care AG's capital expenditures were $238M in Q3 2026 (third quarter 2026), -44% from Q4 2025.
How has Fresenius Medical Care AG's capital expenditures changed?
Over the last 3 quarters it ranged from $192M (Q3 2025) to $423M (Q4 2025).
Q3 2026 results → · How Fresenius Medical Care AG makes money →